Matthias Renner

2.2k total citations · 1 hit paper
42 papers, 1.4k citations indexed

About

Matthias Renner is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Matthias Renner has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 25 papers in Genetics and 10 papers in Oncology. Recurrent topics in Matthias Renner's work include Virus-based gene therapy research (24 papers), CRISPR and Genetic Engineering (17 papers) and RNA Interference and Gene Delivery (9 papers). Matthias Renner is often cited by papers focused on Virus-based gene therapy research (24 papers), CRISPR and Genetic Engineering (17 papers) and RNA Interference and Gene Delivery (9 papers). Matthias Renner collaborates with scholars based in Germany, Austria and Slovakia. Matthias Renner's co-authors include Marcel Volker, W. Fiehn, C. Schneider, E Werle, Juraj Hlavatý, Brian Salmons, Walter H. Günzburg, Zoltán Ivics, Sandra Johnen and Gabriele Thumann and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Matthias Renner

41 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Convenient single-step, one tube purification of PCR products for direct sequencing

1994 592 citations E Werle, C. Schneider et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthias Renner Germany	18	690	558	225	215	164	42	1.4k
Sam Haldenby United Kingdom	14	634 0.9×	257 0.5×	124 0.6×	239 1.1×	110 0.7×	32	1.2k
Marcel Volker Netherlands	13	2.0k 2.8×	385 0.7×	349 1.6×	211 1.0×	272 1.7×	13	2.5k
David Gordon United States	12	1.5k 2.1×	1.1k 1.9×	201 0.9×	105 0.5×	293 1.8×	15	2.1k
Seiyu Hosono United States	14	1.4k 2.1×	572 1.0×	166 0.7×	321 1.5×	237 1.4×	16	2.1k
Paul L. Hallenbeck United States	25	1.5k 2.2×	1.5k 2.6×	484 2.2×	140 0.7×	139 0.8×	39	2.7k
Adam James Waite United States	10	1.7k 2.5×	672 1.2×	84 0.4×	102 0.5×	230 1.4×	15	2.0k
Kurt Wollenberg United States	24	784 1.1×	416 0.7×	94 0.4×	125 0.6×	188 1.1×	49	2.0k
Claude M. Nagamine United States	25	1.0k 1.5×	1.2k 2.1×	174 0.8×	302 1.4×	108 0.7×	54	2.3k
Nobumoto Miyashita Japan	19	632 0.9×	678 1.2×	96 0.4×	205 1.0×	104 0.6×	46	1.3k
Maria F. Bonaldo United States	20	1.3k 1.9×	432 0.8×	109 0.5×	329 1.5×	304 1.9×	26	2.0k

Countries citing papers authored by Matthias Renner

Since Specialization

Citations

This map shows the geographic impact of Matthias Renner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Renner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Renner more than expected).

Fields of papers citing papers by Matthias Renner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Renner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Renner. The network helps show where Matthias Renner may publish in the future.

Co-authorship network of co-authors of Matthias Renner

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Renner. A scholar is included among the top collaborators of Matthias Renner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Renner. Matthias Renner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Habibey, Rouhollah, et al.. (2026). Retinal ganglion cell survival and functional maturation in transiently vascularized human retinal organoids. Cell stem cell. 33(2). 253–271.e13.

Anliker, Brigitte, Liam Childs, Matthias Renner, et al.. (2022). Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal Products. The CRISPR Journal. 5(3). 364–376. 17 indexed citations

Sebe, Attila, et al.. (2020). Genetisch modifizierte regulatorische T-Zellen: Therapiekonzepte und ihr regulatorischer Rahmen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 63(11). 1403–1411. 1 indexed citations

Krackhardt, Angela M., Brigitte Anliker, Martin Hildebrandt, et al.. (2018). Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach. Cancer Immunology Immunotherapy. 67(4). 513–523. 12 indexed citations

Salmikangas, Paula, Martina Schuessler‐Lenz, Patrick Celis, et al.. (2015). Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective. Advances in experimental medicine and biology. 871. 103–130. 48 indexed citations

Renner, Matthias. (2015). Cell therapy clinical trials in Germany – Critical aspects of quality data content. Biologicals. 43(5). 429–432. 1 indexed citations

Abou‐El‐Enein, Mohamed, Gerhard Bauer, Petra Reinke, Matthias Renner, & Christian K. Schneider. (2014). A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIV. Trends in Molecular Medicine. 20(11). 632–642. 16 indexed citations

Aiuti, Alessandro, Giulio Cossu, Pablo de Felipe, et al.. (2013). The Committee for Advanced Therapies' of the European Medicines Agency Reflection Paper on Management of Clinical Risks Deriving from Insertional Mutagenesis. PubMed. 24(2). 47–54. 28 indexed citations

Langer, Barbara, Matthias Renner, Jürgen Scherer, Silke Schüle, & Klaus Cichutek. (2012). Safety Assessment of Biolistic DNA Vaccination. Methods in molecular biology. 940. 371–388. 9 indexed citations

10.

Hlavatý, Juraj, Helga Petznek, Harry Holzmüller, et al.. (2012). Evaluation of a Gene-Directed Enzyme-Product Therapy (GDEPT) in Human Pancreatic Tumor Cells and Their Use as In Vivo Models for Pancreatic Cancer. PLoS ONE. 7(7). e40611–e40611. 11 indexed citations

11.

Klein, Dieter, et al.. (2009). Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors. BMC Molecular Biology. 10(1). 8–8. 5 indexed citations

12.

Lengler, Johannes, Harry Holzmüller, Brian Salmons, Walter H. Günzburg, & Matthias Renner. (2005). FMDV–2A sequence and protein arrangement contribute to functionality of CYP2B1–reporter fusion protein. Analytical Biochemistry. 343(1). 116–124. 35 indexed citations

13.

Hlavatý, Juraj, et al.. (2004). Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors. Virology. 330(1). 351–360. 12 indexed citations

14.

Hohenadl, Christine, et al.. (2002). Specific packaging of spliced retroviral vector transcripts lacking the Ψ-region. Biochemical and Biophysical Research Communications. 293(1). 239–246. 17 indexed citations

15.

Winiarczyk, S., Cornelia Gabler, Gerhardt König, et al.. (2002). JMM — Past and Present. Journal of Molecular Medicine. 80(9). 610–614. 8 indexed citations

16.

Karle, Peter, Matthias Renner, Brian Salmons, & Walter H. Günzburg. (2001). Necrotic, rather than apoptotic, cell death caused by cytochrome P450–activated ifosfamide. Cancer Gene Therapy. 8(3). 220–230. 25 indexed citations

17.

Walter, Ingrid, Dieter Klein, Mathias Müller, et al.. (2000). Rapid and Sensitive Detection of Enhanced Green Fluorescent Protein Expression in Paraffin Sections by Confocal Laser Scanning Microscopy. The Histochemical Journal. 32(2). 99–103. 42 indexed citations

18.

Aigner, Bernhard, Ursula Reichart, U. Besenfelder, et al.. (1999). Species-Specific Alternative Splicing of Transgenic RNA in the Mammary Glands of Pigs, Rabbits, and Mice. Biochemical and Biophysical Research Communications. 257(3). 843–850. 10 indexed citations

19.

Caselmann, Wolfgang H., et al.. (1997). The hepatitis B virus MHBst167 protein is a pleiotropic transactivator mediating its effect via ubiquitous cellular transcription factors.. Journal of General Virology. 78(6). 1487–1495. 17 indexed citations

20.

Werle, E, C. Schneider, Matthias Renner, Marcel Volker, & W. Fiehn. (1994). Convenient single-step, one tube purification of PCR products for direct sequencing. Nucleic Acids Research. 22(20). 4354–4355. 592 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact